Join us for an in-depth and thought-provoking episode featuring Alan White, CEO and Co-founder of Arriello, as we explore the evolving world of global regulatory affairs, pharmacovigilance, quality, and compliance—and the powerful intersection of technology and human expertise that is redefining life sciences.

In this conversation, Alan shares his unconventional journey from a commercial career spanning IT, lighting, and translation services into the highly regulated pharmaceutical sector. He reflects on how early exposure to regulatory-driven services inspired him to found Arriello in 2008, during one of the most challenging global financial climates. From building credibility as a new entrant in a trust-based industry to scaling operations across continents, Alan offers a candid look at what it takes to transform a startup into a global organization supporting clients in more than 140 markets.

We dive into Arriello’s evolution from post-marketing regulatory support into a comprehensive strategic advisory partner spanning clinical development, drug safety, and compliance services. Alan unpacks the realities of navigating fragmented global regulatory systems, the importance of local expertise in global market entry, and the common mistakes biotech companies make when expanding internationally. The discussion also explores the growing role of AI and automation in compliance workflows—and why a human-in-the-loop approach remains essential to ensure accuracy, accountability, and sound judgment.

Episode Highlights:
A deep dive into the inspiration and early challenges behind founding Arriello
Insights into building credibility and trust in global regulatory consulting
The transformation from post-marketing support to full-spectrum strategic advisory services
Practical perspectives on integrating AI and automation while preserving human oversight
A forward-looking vision where regulatory affairs and pharmacovigilance become innovation drivers through digital transformation

Whether you're a biotech founder, regulatory professional, or life sciences executive, this episode offers strategic clarity on how compliance, technology, and leadership intersect in today’s global pharmaceutical landscape. Discover how combining digital capability with human expertise is shaping the future of regulatory excellence and accelerating innovation across life sciences.